SCHEMBL3172697

SCHEMBL3172697

CC(=O)NCCNc1cc(NCCNC(=O)c2ccc(-c3ccccc3)cc2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ADORA3 P0DMS8 2/20 0.46
HIF1A Q16665 1/20 0.46
ALDH1A1 P00352 3/20 0.46
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
MAPT P10636 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
ALOX15 P16050 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175775 0.96 ADORA3 (0.48) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3164769 0.91 GPR139 (0.46) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3155352 0.90 ALDH1A1 (0.47) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3163156 0.90 RAB9A (0.48) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3163394 0.90 ADORA1 (0.51) KMT2AADORA3ALDH1A1ADORA2AADORA1
SCHEMBL3168663 0.89 ADORA1 (0.48) NPC1RAB9ASMN1; SMN2ADORA3ALDH1A1
SCHEMBL3176983 0.89 ADORA3 (0.57) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3163297 0.88 NPC1 (0.55) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3170553 0.88 TP53 (0.53) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3171192 0.88 ADORA3 (0.47) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed